Pulmonary Fibrosis and PDE4B – Video
Pulmonary Fibrosis and PDE4B – Video
Discover the pathophysiology of pulmonary fibrosis.
What you'll learn:
- Which patients may develop pulmonary fibrosis.
- The inflammatory and fibrotic mechanisms that contribute to the pathogenesis and progression of pulmonary fibrosis, including:
- how an initial injury to the epithelium can trigger an abnormal healing response
- how recurring injury results in a proinflammatory and profibrotic milieu and develops into a self-sustaining process of inflammation and fibrosis.
- Current therapeutic targets for pulmonary fibrosis, including phosphodiesterase 4 (PDE4).
- The effects of PDE4 inhibition on epithelial cells, microphages, and fibroblasts.
- Potential side effects of PDE4 inhibition and their impact on the efficacy of potential therapeutic treatments.
Related Resources
SSc-ILD - HCP Resource
Identification and Management of ILD in Systemic Sclerosis - Article
Read evidence-based consensus statements on guidance for the identification and medical management of SSc-ILD.
View Resource
SSc-ILD - HCP Resource
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis ILD - Article
Review the etiology, risk factors, and biomarkers involved in SSc-ILD.
View Resource
SSc-ILD - HCP Resource
Systemic Sclerosis-Associated Interstitial Lung Disease - Slide Deck
Discover the epidemiology, pathogenesis, and diagnosis of SSc-ILD.
View Resource
